nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirbuterol—ADRB2—prostate cancer	0.712	1	CbGaD
Pirbuterol—Terbutaline—ADRB2—prostate cancer	0.00109	0.159	CrCbGaD
Pirbuterol—Nadolol—ADRB2—prostate cancer	0.000902	0.132	CrCbGaD
Pirbuterol—Clenbuterol—ADRB2—prostate cancer	0.00087	0.127	CrCbGaD
Pirbuterol—Bupranolol—ADRB2—prostate cancer	0.00086	0.125	CrCbGaD
Pirbuterol—Salbutamol—ADRB2—prostate cancer	0.000809	0.118	CrCbGaD
Pirbuterol—Clenbuterol—CYP1A1—prostate cancer	0.000746	0.109	CrCbGaD
Pirbuterol—Epinephrine—SLC22A1—prostate cancer	0.000573	0.0836	CrCbGaD
Pirbuterol—Salbutamol—CYP3A4—prostate cancer	0.000443	0.0646	CrCbGaD
Pirbuterol—Epinephrine—ADRB2—prostate cancer	0.000365	0.0533	CrCbGaD
Pirbuterol—Shock—Mitoxantrone—prostate cancer	0.000307	0.00115	CcSEcCtD
Pirbuterol—Muscle spasms—Etoposide—prostate cancer	0.000305	0.00114	CcSEcCtD
Pirbuterol—Nausea—Ethinyl Estradiol—prostate cancer	0.000304	0.00114	CcSEcCtD
Pirbuterol—Tachycardia—Mitoxantrone—prostate cancer	0.000304	0.00114	CcSEcCtD
Pirbuterol—Asthenia—Goserelin—prostate cancer	0.000303	0.00113	CcSEcCtD
Pirbuterol—Insomnia—Estradiol—prostate cancer	0.000303	0.00113	CcSEcCtD
Pirbuterol—Hypoaesthesia—Docetaxel—prostate cancer	0.000302	0.00113	CcSEcCtD
Pirbuterol—Asthenia—Conjugated Estrogens—prostate cancer	0.0003	0.00112	CcSEcCtD
Pirbuterol—Pruritus—Goserelin—prostate cancer	0.000298	0.00112	CcSEcCtD
Pirbuterol—Somnolence—Estradiol—prostate cancer	0.000297	0.00111	CcSEcCtD
Pirbuterol—Weight increased—Prednisone—prostate cancer	0.000297	0.00111	CcSEcCtD
Pirbuterol—Anorexia—Mitoxantrone—prostate cancer	0.000297	0.00111	CcSEcCtD
Pirbuterol—Pruritus—Conjugated Estrogens—prostate cancer	0.000296	0.00111	CcSEcCtD
Pirbuterol—Hypoaesthesia—Capecitabine—prostate cancer	0.000292	0.00109	CcSEcCtD
Pirbuterol—Hypotension—Mitoxantrone—prostate cancer	0.000291	0.00109	CcSEcCtD
Pirbuterol—Migraine—Epirubicin—prostate cancer	0.000291	0.00109	CcSEcCtD
Pirbuterol—Decreased appetite—Estradiol—prostate cancer	0.000291	0.00109	CcSEcCtD
Pirbuterol—Diarrhoea—Goserelin—prostate cancer	0.000289	0.00108	CcSEcCtD
Pirbuterol—Fatigue—Estradiol—prostate cancer	0.000288	0.00108	CcSEcCtD
Pirbuterol—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000286	0.00107	CcSEcCtD
Pirbuterol—Flushing—Docetaxel—prostate cancer	0.000281	0.00105	CcSEcCtD
Pirbuterol—Loss of consciousness—Etoposide—prostate cancer	0.000279	0.00104	CcSEcCtD
Pirbuterol—Dizziness—Goserelin—prostate cancer	0.000279	0.00104	CcSEcCtD
Pirbuterol—Cough—Etoposide—prostate cancer	0.000277	0.00104	CcSEcCtD
Pirbuterol—Somnolence—Mitoxantrone—prostate cancer	0.000277	0.00104	CcSEcCtD
Pirbuterol—Dizziness—Conjugated Estrogens—prostate cancer	0.000276	0.00103	CcSEcCtD
Pirbuterol—Feeling abnormal—Estradiol—prostate cancer	0.000276	0.00103	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Estradiol—prostate cancer	0.000273	0.00102	CcSEcCtD
Pirbuterol—Flushing—Capecitabine—prostate cancer	0.000272	0.00102	CcSEcCtD
Pirbuterol—Decreased appetite—Mitoxantrone—prostate cancer	0.000271	0.00101	CcSEcCtD
Pirbuterol—Chest pain—Etoposide—prostate cancer	0.00027	0.00101	CcSEcCtD
Pirbuterol—Migraine—Doxorubicin—prostate cancer	0.000269	0.00101	CcSEcCtD
Pirbuterol—Fatigue—Mitoxantrone—prostate cancer	0.000269	0.001	CcSEcCtD
Pirbuterol—Vomiting—Goserelin—prostate cancer	0.000268	0.001	CcSEcCtD
Pirbuterol—Alopecia—Docetaxel—prostate cancer	0.000268	0.001	CcSEcCtD
Pirbuterol—Rash—Goserelin—prostate cancer	0.000266	0.000995	CcSEcCtD
Pirbuterol—Dermatitis—Goserelin—prostate cancer	0.000266	0.000994	CcSEcCtD
Pirbuterol—Vomiting—Conjugated Estrogens—prostate cancer	0.000266	0.000993	CcSEcCtD
Pirbuterol—Abdominal pain—Estradiol—prostate cancer	0.000264	0.000988	CcSEcCtD
Pirbuterol—Headache—Goserelin—prostate cancer	0.000264	0.000988	CcSEcCtD
Pirbuterol—Rash—Conjugated Estrogens—prostate cancer	0.000263	0.000985	CcSEcCtD
Pirbuterol—Dermatitis—Conjugated Estrogens—prostate cancer	0.000263	0.000984	CcSEcCtD
Pirbuterol—Headache—Conjugated Estrogens—prostate cancer	0.000262	0.000979	CcSEcCtD
Pirbuterol—Confusional state—Etoposide—prostate cancer	0.000261	0.000977	CcSEcCtD
Pirbuterol—Alopecia—Capecitabine—prostate cancer	0.000259	0.00097	CcSEcCtD
Pirbuterol—Feeling abnormal—Mitoxantrone—prostate cancer	0.000257	0.00096	CcSEcCtD
Pirbuterol—Back pain—Docetaxel—prostate cancer	0.000255	0.000955	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000255	0.000953	CcSEcCtD
Pirbuterol—Muscle spasms—Docetaxel—prostate cancer	0.000254	0.000949	CcSEcCtD
Pirbuterol—Tachycardia—Etoposide—prostate cancer	0.000253	0.000946	CcSEcCtD
Pirbuterol—Nausea—Goserelin—prostate cancer	0.000251	0.000937	CcSEcCtD
Pirbuterol—Nausea—Conjugated Estrogens—prostate cancer	0.000248	0.000928	CcSEcCtD
Pirbuterol—Back pain—Capecitabine—prostate cancer	0.000247	0.000924	CcSEcCtD
Pirbuterol—Anorexia—Etoposide—prostate cancer	0.000247	0.000924	CcSEcCtD
Pirbuterol—Abdominal pain—Mitoxantrone—prostate cancer	0.000246	0.000921	CcSEcCtD
Pirbuterol—Muscle spasms—Capecitabine—prostate cancer	0.000246	0.000919	CcSEcCtD
Pirbuterol—Flushing—Prednisone—prostate cancer	0.000243	0.000907	CcSEcCtD
Pirbuterol—Hypotension—Etoposide—prostate cancer	0.000242	0.000906	CcSEcCtD
Pirbuterol—Asthenia—Estradiol—prostate cancer	0.00024	0.000897	CcSEcCtD
Pirbuterol—Tremor—Capecitabine—prostate cancer	0.000239	0.000895	CcSEcCtD
Pirbuterol—Syncope—Docetaxel—prostate cancer	0.000237	0.000885	CcSEcCtD
Pirbuterol—Pruritus—Estradiol—prostate cancer	0.000237	0.000885	CcSEcCtD
Pirbuterol—Palpitations—Docetaxel—prostate cancer	0.000233	0.000872	CcSEcCtD
Pirbuterol—Weight increased—Epirubicin—prostate cancer	0.000233	0.000869	CcSEcCtD
Pirbuterol—Loss of consciousness—Docetaxel—prostate cancer	0.000232	0.000867	CcSEcCtD
Pirbuterol—Alopecia—Prednisone—prostate cancer	0.000231	0.000864	CcSEcCtD
Pirbuterol—Somnolence—Etoposide—prostate cancer	0.00023	0.000862	CcSEcCtD
Pirbuterol—Cough—Docetaxel—prostate cancer	0.00023	0.000861	CcSEcCtD
Pirbuterol—Syncope—Capecitabine—prostate cancer	0.000229	0.000857	CcSEcCtD
Pirbuterol—Diarrhoea—Estradiol—prostate cancer	0.000229	0.000856	CcSEcCtD
Pirbuterol—Drowsiness—Epirubicin—prostate cancer	0.000228	0.000852	CcSEcCtD
Pirbuterol—Palpitations—Capecitabine—prostate cancer	0.000226	0.000844	CcSEcCtD
Pirbuterol—Decreased appetite—Etoposide—prostate cancer	0.000225	0.000842	CcSEcCtD
Pirbuterol—Chest pain—Docetaxel—prostate cancer	0.000225	0.00084	CcSEcCtD
Pirbuterol—Loss of consciousness—Capecitabine—prostate cancer	0.000225	0.00084	CcSEcCtD
Pirbuterol—Asthenia—Mitoxantrone—prostate cancer	0.000224	0.000836	CcSEcCtD
Pirbuterol—Fatigue—Etoposide—prostate cancer	0.000223	0.000836	CcSEcCtD
Pirbuterol—Cough—Capecitabine—prostate cancer	0.000223	0.000834	CcSEcCtD
Pirbuterol—Stomatitis—Epirubicin—prostate cancer	0.000222	0.00083	CcSEcCtD
Pirbuterol—Dizziness—Estradiol—prostate cancer	0.000221	0.000827	CcSEcCtD
Pirbuterol—Dry mouth—Docetaxel—prostate cancer	0.00022	0.000822	CcSEcCtD
Pirbuterol—Chest pain—Capecitabine—prostate cancer	0.000218	0.000813	CcSEcCtD
Pirbuterol—Confusional state—Docetaxel—prostate cancer	0.000217	0.000812	CcSEcCtD
Pirbuterol—Anxiety—Capecitabine—prostate cancer	0.000217	0.000811	CcSEcCtD
Pirbuterol—Oedema—Docetaxel—prostate cancer	0.000215	0.000805	CcSEcCtD
Pirbuterol—Weight increased—Doxorubicin—prostate cancer	0.000215	0.000804	CcSEcCtD
Pirbuterol—Feeling abnormal—Etoposide—prostate cancer	0.000214	0.000799	CcSEcCtD
Pirbuterol—Diarrhoea—Mitoxantrone—prostate cancer	0.000213	0.000797	CcSEcCtD
Pirbuterol—Dry mouth—Capecitabine—prostate cancer	0.000213	0.000796	CcSEcCtD
Pirbuterol—Vomiting—Estradiol—prostate cancer	0.000213	0.000795	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Etoposide—prostate cancer	0.000212	0.000792	CcSEcCtD
Pirbuterol—Shock—Docetaxel—prostate cancer	0.000212	0.000792	CcSEcCtD
Pirbuterol—Rash—Estradiol—prostate cancer	0.000211	0.000788	CcSEcCtD
Pirbuterol—Drowsiness—Doxorubicin—prostate cancer	0.000211	0.000788	CcSEcCtD
Pirbuterol—Dermatitis—Estradiol—prostate cancer	0.000211	0.000788	CcSEcCtD
Pirbuterol—Confusional state—Capecitabine—prostate cancer	0.00021	0.000786	CcSEcCtD
Pirbuterol—Tachycardia—Docetaxel—prostate cancer	0.00021	0.000786	CcSEcCtD
Pirbuterol—Headache—Estradiol—prostate cancer	0.00021	0.000783	CcSEcCtD
Pirbuterol—Agitation—Prednisone—prostate cancer	0.000209	0.000782	CcSEcCtD
Pirbuterol—Oedema—Capecitabine—prostate cancer	0.000209	0.00078	CcSEcCtD
Pirbuterol—Stomatitis—Doxorubicin—prostate cancer	0.000205	0.000768	CcSEcCtD
Pirbuterol—Anorexia—Docetaxel—prostate cancer	0.000205	0.000768	CcSEcCtD
Pirbuterol—Shock—Capecitabine—prostate cancer	0.000205	0.000767	CcSEcCtD
Pirbuterol—Abdominal pain—Etoposide—prostate cancer	0.000205	0.000766	CcSEcCtD
Pirbuterol—Syncope—Prednisone—prostate cancer	0.000204	0.000763	CcSEcCtD
Pirbuterol—Tachycardia—Capecitabine—prostate cancer	0.000204	0.000761	CcSEcCtD
Pirbuterol—Hypoaesthesia—Epirubicin—prostate cancer	0.000203	0.000761	CcSEcCtD
Pirbuterol—Hypotension—Docetaxel—prostate cancer	0.000201	0.000753	CcSEcCtD
Pirbuterol—Loss of consciousness—Prednisone—prostate cancer	0.0002	0.000748	CcSEcCtD
Pirbuterol—Epinephrine—CYP3A4—prostate cancer	0.0002	0.0292	CrCbGaD
Pirbuterol—Anorexia—Capecitabine—prostate cancer	0.000199	0.000743	CcSEcCtD
Pirbuterol—Nausea—Estradiol—prostate cancer	0.000199	0.000743	CcSEcCtD
Pirbuterol—Vomiting—Mitoxantrone—prostate cancer	0.000198	0.000741	CcSEcCtD
Pirbuterol—Rash—Mitoxantrone—prostate cancer	0.000196	0.000735	CcSEcCtD
Pirbuterol—Dermatitis—Mitoxantrone—prostate cancer	0.000196	0.000734	CcSEcCtD
Pirbuterol—Headache—Mitoxantrone—prostate cancer	0.000195	0.00073	CcSEcCtD
Pirbuterol—Hypotension—Capecitabine—prostate cancer	0.000195	0.000729	CcSEcCtD
Pirbuterol—Insomnia—Docetaxel—prostate cancer	0.000195	0.000728	CcSEcCtD
Pirbuterol—Anxiety—Prednisone—prostate cancer	0.000193	0.000722	CcSEcCtD
Pirbuterol—Somnolence—Docetaxel—prostate cancer	0.000192	0.000716	CcSEcCtD
Pirbuterol—Flushing—Epirubicin—prostate cancer	0.00019	0.00071	CcSEcCtD
Pirbuterol—Insomnia—Capecitabine—prostate cancer	0.000189	0.000705	CcSEcCtD
Pirbuterol—Hypoaesthesia—Doxorubicin—prostate cancer	0.000188	0.000704	CcSEcCtD
Pirbuterol—Decreased appetite—Docetaxel—prostate cancer	0.000187	0.0007	CcSEcCtD
Pirbuterol—Asthenia—Etoposide—prostate cancer	0.000186	0.000695	CcSEcCtD
Pirbuterol—Oedema—Prednisone—prostate cancer	0.000186	0.000695	CcSEcCtD
Pirbuterol—Fatigue—Docetaxel—prostate cancer	0.000186	0.000694	CcSEcCtD
Pirbuterol—Nausea—Mitoxantrone—prostate cancer	0.000185	0.000692	CcSEcCtD
Pirbuterol—Pruritus—Etoposide—prostate cancer	0.000183	0.000686	CcSEcCtD
Pirbuterol—Shock—Prednisone—prostate cancer	0.000183	0.000683	CcSEcCtD
Pirbuterol—Tachycardia—Prednisone—prostate cancer	0.000181	0.000678	CcSEcCtD
Pirbuterol—Decreased appetite—Capecitabine—prostate cancer	0.000181	0.000678	CcSEcCtD
Pirbuterol—Alopecia—Epirubicin—prostate cancer	0.000181	0.000676	CcSEcCtD
Pirbuterol—Fatigue—Capecitabine—prostate cancer	0.00018	0.000672	CcSEcCtD
Pirbuterol—Feeling abnormal—Docetaxel—prostate cancer	0.000178	0.000664	CcSEcCtD
Pirbuterol—Diarrhoea—Etoposide—prostate cancer	0.000177	0.000663	CcSEcCtD
Pirbuterol—Anorexia—Prednisone—prostate cancer	0.000177	0.000662	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Docetaxel—prostate cancer	0.000176	0.000659	CcSEcCtD
Pirbuterol—Flushing—Doxorubicin—prostate cancer	0.000176	0.000657	CcSEcCtD
Pirbuterol—Tension—Epirubicin—prostate cancer	0.000175	0.000653	CcSEcCtD
Pirbuterol—Nervousness—Epirubicin—prostate cancer	0.000173	0.000646	CcSEcCtD
Pirbuterol—Back pain—Epirubicin—prostate cancer	0.000172	0.000644	CcSEcCtD
Pirbuterol—Feeling abnormal—Capecitabine—prostate cancer	0.000172	0.000643	CcSEcCtD
Pirbuterol—Dizziness—Etoposide—prostate cancer	0.000171	0.000641	CcSEcCtD
Pirbuterol—Muscle spasms—Epirubicin—prostate cancer	0.000171	0.00064	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Capecitabine—prostate cancer	0.000171	0.000638	CcSEcCtD
Pirbuterol—Abdominal pain—Docetaxel—prostate cancer	0.00017	0.000637	CcSEcCtD
Pirbuterol—Insomnia—Prednisone—prostate cancer	0.000168	0.000628	CcSEcCtD
Pirbuterol—Alopecia—Doxorubicin—prostate cancer	0.000167	0.000625	CcSEcCtD
Pirbuterol—Abdominal pain—Capecitabine—prostate cancer	0.000165	0.000616	CcSEcCtD
Pirbuterol—Vomiting—Etoposide—prostate cancer	0.000165	0.000616	CcSEcCtD
Pirbuterol—Agitation—Epirubicin—prostate cancer	0.000164	0.000612	CcSEcCtD
Pirbuterol—Rash—Etoposide—prostate cancer	0.000163	0.000611	CcSEcCtD
Pirbuterol—Dermatitis—Etoposide—prostate cancer	0.000163	0.00061	CcSEcCtD
Pirbuterol—Headache—Etoposide—prostate cancer	0.000162	0.000607	CcSEcCtD
Pirbuterol—Tension—Doxorubicin—prostate cancer	0.000162	0.000604	CcSEcCtD
Pirbuterol—Decreased appetite—Prednisone—prostate cancer	0.000162	0.000604	CcSEcCtD
Pirbuterol—Fatigue—Prednisone—prostate cancer	0.00016	0.000599	CcSEcCtD
Pirbuterol—Nervousness—Doxorubicin—prostate cancer	0.00016	0.000598	CcSEcCtD
Pirbuterol—Syncope—Epirubicin—prostate cancer	0.00016	0.000597	CcSEcCtD
Pirbuterol—Back pain—Doxorubicin—prostate cancer	0.000159	0.000596	CcSEcCtD
Pirbuterol—Muscle spasms—Doxorubicin—prostate cancer	0.000158	0.000592	CcSEcCtD
Pirbuterol—Palpitations—Epirubicin—prostate cancer	0.000157	0.000588	CcSEcCtD
Pirbuterol—Loss of consciousness—Epirubicin—prostate cancer	0.000156	0.000585	CcSEcCtD
Pirbuterol—Cough—Epirubicin—prostate cancer	0.000155	0.000581	CcSEcCtD
Pirbuterol—Asthenia—Docetaxel—prostate cancer	0.000155	0.000578	CcSEcCtD
Pirbuterol—Nausea—Etoposide—prostate cancer	0.000154	0.000576	CcSEcCtD
Pirbuterol—Feeling abnormal—Prednisone—prostate cancer	0.000153	0.000572	CcSEcCtD
Pirbuterol—Pruritus—Docetaxel—prostate cancer	0.000152	0.00057	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Prednisone—prostate cancer	0.000152	0.000568	CcSEcCtD
Pirbuterol—Chest pain—Epirubicin—prostate cancer	0.000152	0.000567	CcSEcCtD
Pirbuterol—Agitation—Doxorubicin—prostate cancer	0.000151	0.000566	CcSEcCtD
Pirbuterol—Anxiety—Epirubicin—prostate cancer	0.000151	0.000565	CcSEcCtD
Pirbuterol—Asthenia—Capecitabine—prostate cancer	0.00015	0.000559	CcSEcCtD
Pirbuterol—Dry mouth—Epirubicin—prostate cancer	0.000148	0.000554	CcSEcCtD
Pirbuterol—Syncope—Doxorubicin—prostate cancer	0.000148	0.000552	CcSEcCtD
Pirbuterol—Pruritus—Capecitabine—prostate cancer	0.000148	0.000552	CcSEcCtD
Pirbuterol—Diarrhoea—Docetaxel—prostate cancer	0.000147	0.000551	CcSEcCtD
Pirbuterol—Abdominal pain—Prednisone—prostate cancer	0.000147	0.000549	CcSEcCtD
Pirbuterol—Confusional state—Epirubicin—prostate cancer	0.000147	0.000548	CcSEcCtD
Pirbuterol—Palpitations—Doxorubicin—prostate cancer	0.000146	0.000544	CcSEcCtD
Pirbuterol—Oedema—Epirubicin—prostate cancer	0.000145	0.000543	CcSEcCtD
Pirbuterol—Loss of consciousness—Doxorubicin—prostate cancer	0.000145	0.000541	CcSEcCtD
Pirbuterol—Cough—Doxorubicin—prostate cancer	0.000144	0.000537	CcSEcCtD
Pirbuterol—Shock—Epirubicin—prostate cancer	0.000143	0.000534	CcSEcCtD
Pirbuterol—Diarrhoea—Capecitabine—prostate cancer	0.000143	0.000534	CcSEcCtD
Pirbuterol—Dizziness—Docetaxel—prostate cancer	0.000142	0.000533	CcSEcCtD
Pirbuterol—Tachycardia—Epirubicin—prostate cancer	0.000142	0.00053	CcSEcCtD
Pirbuterol—Chest pain—Doxorubicin—prostate cancer	0.00014	0.000524	CcSEcCtD
Pirbuterol—Anxiety—Doxorubicin—prostate cancer	0.00014	0.000523	CcSEcCtD
Pirbuterol—Anorexia—Epirubicin—prostate cancer	0.000139	0.000518	CcSEcCtD
Pirbuterol—Dizziness—Capecitabine—prostate cancer	0.000138	0.000516	CcSEcCtD
Pirbuterol—Dry mouth—Doxorubicin—prostate cancer	0.000137	0.000513	CcSEcCtD
Pirbuterol—Vomiting—Docetaxel—prostate cancer	0.000137	0.000512	CcSEcCtD
Pirbuterol—Rash—Docetaxel—prostate cancer	0.000136	0.000508	CcSEcCtD
Pirbuterol—Hypotension—Epirubicin—prostate cancer	0.000136	0.000508	CcSEcCtD
Pirbuterol—Dermatitis—Docetaxel—prostate cancer	0.000136	0.000507	CcSEcCtD
Pirbuterol—Confusional state—Doxorubicin—prostate cancer	0.000136	0.000507	CcSEcCtD
Pirbuterol—Headache—Docetaxel—prostate cancer	0.000135	0.000505	CcSEcCtD
Pirbuterol—Oedema—Doxorubicin—prostate cancer	0.000134	0.000503	CcSEcCtD
Pirbuterol—Asthenia—Prednisone—prostate cancer	0.000133	0.000498	CcSEcCtD
Pirbuterol—Vomiting—Capecitabine—prostate cancer	0.000133	0.000496	CcSEcCtD
Pirbuterol—Shock—Doxorubicin—prostate cancer	0.000132	0.000495	CcSEcCtD
Pirbuterol—Rash—Capecitabine—prostate cancer	0.000132	0.000492	CcSEcCtD
Pirbuterol—Pruritus—Prednisone—prostate cancer	0.000131	0.000491	CcSEcCtD
Pirbuterol—Insomnia—Epirubicin—prostate cancer	0.000131	0.000491	CcSEcCtD
Pirbuterol—Dermatitis—Capecitabine—prostate cancer	0.000131	0.000491	CcSEcCtD
Pirbuterol—Tachycardia—Doxorubicin—prostate cancer	0.000131	0.000491	CcSEcCtD
Pirbuterol—Headache—Capecitabine—prostate cancer	0.000131	0.000488	CcSEcCtD
Pirbuterol—Somnolence—Epirubicin—prostate cancer	0.000129	0.000483	CcSEcCtD
Pirbuterol—Anorexia—Doxorubicin—prostate cancer	0.000128	0.000479	CcSEcCtD
Pirbuterol—Nausea—Docetaxel—prostate cancer	0.000128	0.000478	CcSEcCtD
Pirbuterol—Diarrhoea—Prednisone—prostate cancer	0.000127	0.000475	CcSEcCtD
Pirbuterol—Decreased appetite—Epirubicin—prostate cancer	0.000126	0.000472	CcSEcCtD
Pirbuterol—Hypotension—Doxorubicin—prostate cancer	0.000126	0.00047	CcSEcCtD
Pirbuterol—Fatigue—Epirubicin—prostate cancer	0.000125	0.000468	CcSEcCtD
Pirbuterol—Nausea—Capecitabine—prostate cancer	0.000124	0.000463	CcSEcCtD
Pirbuterol—Dizziness—Prednisone—prostate cancer	0.000123	0.000459	CcSEcCtD
Pirbuterol—Insomnia—Doxorubicin—prostate cancer	0.000122	0.000455	CcSEcCtD
Pirbuterol—Feeling abnormal—Epirubicin—prostate cancer	0.00012	0.000448	CcSEcCtD
Pirbuterol—Somnolence—Doxorubicin—prostate cancer	0.00012	0.000447	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Epirubicin—prostate cancer	0.000119	0.000444	CcSEcCtD
Pirbuterol—Vomiting—Prednisone—prostate cancer	0.000118	0.000442	CcSEcCtD
Pirbuterol—Rash—Prednisone—prostate cancer	0.000117	0.000438	CcSEcCtD
Pirbuterol—Dermatitis—Prednisone—prostate cancer	0.000117	0.000438	CcSEcCtD
Pirbuterol—Decreased appetite—Doxorubicin—prostate cancer	0.000117	0.000437	CcSEcCtD
Pirbuterol—Headache—Prednisone—prostate cancer	0.000116	0.000435	CcSEcCtD
Pirbuterol—Fatigue—Doxorubicin—prostate cancer	0.000116	0.000433	CcSEcCtD
Pirbuterol—Abdominal pain—Epirubicin—prostate cancer	0.000115	0.000429	CcSEcCtD
Pirbuterol—Feeling abnormal—Doxorubicin—prostate cancer	0.000111	0.000414	CcSEcCtD
Pirbuterol—Nausea—Prednisone—prostate cancer	0.00011	0.000413	CcSEcCtD
Pirbuterol—Gastrointestinal pain—Doxorubicin—prostate cancer	0.00011	0.000411	CcSEcCtD
Pirbuterol—Abdominal pain—Doxorubicin—prostate cancer	0.000106	0.000397	CcSEcCtD
Pirbuterol—Asthenia—Epirubicin—prostate cancer	0.000104	0.00039	CcSEcCtD
Pirbuterol—Pruritus—Epirubicin—prostate cancer	0.000103	0.000384	CcSEcCtD
Pirbuterol—Diarrhoea—Epirubicin—prostate cancer	9.94e-05	0.000372	CcSEcCtD
Pirbuterol—Asthenia—Doxorubicin—prostate cancer	9.65e-05	0.000361	CcSEcCtD
Pirbuterol—Dizziness—Epirubicin—prostate cancer	9.61e-05	0.000359	CcSEcCtD
Pirbuterol—Pruritus—Doxorubicin—prostate cancer	9.51e-05	0.000356	CcSEcCtD
Pirbuterol—Vomiting—Epirubicin—prostate cancer	9.24e-05	0.000345	CcSEcCtD
Pirbuterol—Diarrhoea—Doxorubicin—prostate cancer	9.2e-05	0.000344	CcSEcCtD
Pirbuterol—Rash—Epirubicin—prostate cancer	9.16e-05	0.000343	CcSEcCtD
Pirbuterol—Dermatitis—Epirubicin—prostate cancer	9.15e-05	0.000342	CcSEcCtD
Pirbuterol—Headache—Epirubicin—prostate cancer	9.1e-05	0.00034	CcSEcCtD
Pirbuterol—Dizziness—Doxorubicin—prostate cancer	8.89e-05	0.000332	CcSEcCtD
Pirbuterol—Nausea—Epirubicin—prostate cancer	8.63e-05	0.000323	CcSEcCtD
Pirbuterol—Vomiting—Doxorubicin—prostate cancer	8.55e-05	0.00032	CcSEcCtD
Pirbuterol—Rash—Doxorubicin—prostate cancer	8.48e-05	0.000317	CcSEcCtD
Pirbuterol—Dermatitis—Doxorubicin—prostate cancer	8.47e-05	0.000317	CcSEcCtD
Pirbuterol—Headache—Doxorubicin—prostate cancer	8.42e-05	0.000315	CcSEcCtD
Pirbuterol—Nausea—Doxorubicin—prostate cancer	7.99e-05	0.000299	CcSEcCtD
Pirbuterol—ADRB2—Signaling Pathways—RALBP1—prostate cancer	1.65e-05	0.00119	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PTHLH—prostate cancer	1.64e-05	0.00118	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PRKACB—prostate cancer	1.61e-05	0.00116	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PTHLH—prostate cancer	1.6e-05	0.00115	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CALCA—prostate cancer	1.59e-05	0.00114	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PRKACB—prostate cancer	1.57e-05	0.00113	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PPP3CA—prostate cancer	1.56e-05	0.00113	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CALCA—prostate cancer	1.56e-05	0.00112	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CXCL12—prostate cancer	1.55e-05	0.00112	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—ANXA1—prostate cancer	1.54e-05	0.00111	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PPP3CA—prostate cancer	1.53e-05	0.0011	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CXCL12—prostate cancer	1.52e-05	0.00109	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—ANXA1—prostate cancer	1.51e-05	0.00109	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PENK—prostate cancer	1.5e-05	0.00108	CbGpPWpGaD
Pirbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	1.5e-05	0.00108	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PENK—prostate cancer	1.47e-05	0.00106	CbGpPWpGaD
Pirbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	1.46e-05	0.00105	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CALCA—prostate cancer	1.44e-05	0.00104	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GHR—prostate cancer	1.43e-05	0.00103	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PRKCQ—prostate cancer	1.42e-05	0.00102	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CALCA—prostate cancer	1.41e-05	0.00102	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CXCL12—prostate cancer	1.41e-05	0.00102	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GHR—prostate cancer	1.4e-05	0.00101	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PRKCQ—prostate cancer	1.39e-05	0.000998	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CXCL12—prostate cancer	1.38e-05	0.000993	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NRP1—prostate cancer	1.38e-05	0.00099	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NRP1—prostate cancer	1.35e-05	0.000968	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—ADRB2—prostate cancer	1.33e-05	0.000959	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—VAV3—prostate cancer	1.3e-05	0.000935	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PRKCQ—prostate cancer	1.29e-05	0.000926	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GNRH1—prostate cancer	1.28e-05	0.00092	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VIP—prostate cancer	1.28e-05	0.00092	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—VAV3—prostate cancer	1.27e-05	0.000915	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—ITPR1—prostate cancer	1.26e-05	0.000907	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PRKCQ—prostate cancer	1.26e-05	0.000906	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GNRH1—prostate cancer	1.25e-05	0.0009	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VIP—prostate cancer	1.25e-05	0.0009	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GRP—prostate cancer	1.24e-05	0.000891	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LPAR1—prostate cancer	1.24e-05	0.000891	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—ITPR1—prostate cancer	1.23e-05	0.000887	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LRP2—prostate cancer	1.23e-05	0.000882	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PLCB2—prostate cancer	1.23e-05	0.000882	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LPAR1—prostate cancer	1.21e-05	0.000872	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GRP—prostate cancer	1.21e-05	0.000872	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—ADRB2—prostate cancer	1.21e-05	0.000871	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—P4HB—prostate cancer	1.2e-05	0.000865	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CX3CL1—prostate cancer	1.2e-05	0.000865	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PLCB2—prostate cancer	1.2e-05	0.000863	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LRP2—prostate cancer	1.2e-05	0.000863	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—VAV3—prostate cancer	1.18e-05	0.000849	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HIST1H2BG—prostate cancer	1.18e-05	0.000849	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CX3CL1—prostate cancer	1.18e-05	0.000846	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—P4HB—prostate cancer	1.18e-05	0.000846	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GRB7—prostate cancer	1.17e-05	0.000842	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDE4D—prostate cancer	1.17e-05	0.000842	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—VAV3—prostate cancer	1.15e-05	0.000831	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HIST1H2BG—prostate cancer	1.15e-05	0.000831	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—ITPR1—prostate cancer	1.14e-05	0.000824	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDE4D—prostate cancer	1.14e-05	0.000823	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GRB7—prostate cancer	1.14e-05	0.000823	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HIST1H4H—prostate cancer	1.14e-05	0.00082	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR ligand binding—CXCL8—prostate cancer	1.14e-05	0.00082	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—ITPR1—prostate cancer	1.12e-05	0.000806	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HIST1H4H—prostate cancer	1.11e-05	0.000802	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR ligand binding—CXCL8—prostate cancer	1.11e-05	0.000802	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GNG5—prostate cancer	1.11e-05	0.000801	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GNG5—prostate cancer	1.09e-05	0.000783	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTHLH—prostate cancer	9.69e-06	0.000697	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFBR1—prostate cancer	9.69e-06	0.000697	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKR1C3—prostate cancer	9.53e-06	0.000686	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKACB—prostate cancer	9.48e-06	0.000682	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTHLH—prostate cancer	9.48e-06	0.000682	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFBR1—prostate cancer	9.48e-06	0.000682	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKR1C3—prostate cancer	9.33e-06	0.000671	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKACB—prostate cancer	9.28e-06	0.000668	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—THBS1—prostate cancer	9.24e-06	0.000665	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PPP3CA—prostate cancer	9.24e-06	0.000665	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ANXA1—prostate cancer	9.11e-06	0.000656	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—THBS1—prostate cancer	9.04e-06	0.000651	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PPP3CA—prostate cancer	9.04e-06	0.000651	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCZ—prostate cancer	8.94e-06	0.000644	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ANXA1—prostate cancer	8.91e-06	0.000641	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCZ—prostate cancer	8.75e-06	0.00063	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CG—prostate cancer	8.74e-06	0.000629	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PARP1—prostate cancer	8.64e-06	0.000622	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGFR4—prostate cancer	8.64e-06	0.000622	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CG—prostate cancer	8.55e-06	0.000615	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CALCA—prostate cancer	8.53e-06	0.000614	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PARP1—prostate cancer	8.45e-06	0.000608	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGFR4—prostate cancer	8.45e-06	0.000608	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CALCA—prostate cancer	8.35e-06	0.000601	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCL12—prostate cancer	8.33e-06	0.0006	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCL12—prostate cancer	8.15e-06	0.000587	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CG—prostate cancer	7.94e-06	0.000571	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CASP9—prostate cancer	7.85e-06	0.000565	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CG—prostate cancer	7.76e-06	0.000559	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CD—prostate cancer	7.68e-06	0.000553	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CASP9—prostate cancer	7.68e-06	0.000552	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PRKCQ—prostate cancer	7.6e-06	0.000547	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NGFR—prostate cancer	7.6e-06	0.000547	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CD—prostate cancer	7.52e-06	0.000541	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAP3K7—prostate cancer	7.51e-06	0.000541	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PRKCQ—prostate cancer	7.44e-06	0.000535	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NGFR—prostate cancer	7.44e-06	0.000535	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAP3K7—prostate cancer	7.35e-06	0.000529	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF10—prostate cancer	7.22e-06	0.00052	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ADRB2—prostate cancer	7.15e-06	0.000515	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF10—prostate cancer	7.07e-06	0.000509	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—JAK2—prostate cancer	7.05e-06	0.000508	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—MAP2K1—prostate cancer	7.02e-06	0.000506	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CD—prostate cancer	6.98e-06	0.000502	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VAV3—prostate cancer	6.97e-06	0.000502	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—JAK2—prostate cancer	6.9e-06	0.000496	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFBR2—prostate cancer	6.87e-06	0.000495	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—MAP2K1—prostate cancer	6.87e-06	0.000495	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CD—prostate cancer	6.83e-06	0.000491	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VAV3—prostate cancer	6.82e-06	0.000491	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ITPR1—prostate cancer	6.76e-06	0.000487	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFBR2—prostate cancer	6.72e-06	0.000484	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CB—prostate cancer	6.7e-06	0.000482	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ITPR1—prostate cancer	6.61e-06	0.000476	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CB—prostate cancer	6.55e-06	0.000472	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1R—prostate cancer	6.47e-06	0.000465	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—CXCL8—prostate cancer	6.44e-06	0.000463	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—JAK2—prostate cancer	6.4e-06	0.000461	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1R—prostate cancer	6.32e-06	0.000455	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—CXCL8—prostate cancer	6.3e-06	0.000453	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—JAK2—prostate cancer	6.26e-06	0.000451	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LPL—prostate cancer	6.2e-06	0.000446	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—IL2—prostate cancer	6.15e-06	0.000443	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PDGFRB—prostate cancer	6.14e-06	0.000442	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CB—prostate cancer	6.08e-06	0.000438	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LPL—prostate cancer	6.06e-06	0.000436	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	6.02e-06	0.000433	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	6.01e-06	0.000432	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	5.99e-06	0.000431	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	5.95e-06	0.000428	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	5.86e-06	0.000421	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	5.84e-06	0.000421	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	5.81e-06	0.000418	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	5.8e-06	0.000417	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	5.72e-06	0.000411	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	5.68e-06	0.000409	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	5.67e-06	0.000408	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL2—prostate cancer	5.59e-06	0.000402	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TERT—prostate cancer	5.57e-06	0.000401	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL2—prostate cancer	5.46e-06	0.000393	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TERT—prostate cancer	5.44e-06	0.000392	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	5.32e-06	0.000383	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	5.21e-06	0.000375	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—LEP—prostate cancer	5.2e-06	0.000374	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CAV1—prostate cancer	5.15e-06	0.00037	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KDR—prostate cancer	5.09e-06	0.000366	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—LEP—prostate cancer	5.08e-06	0.000366	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CAV1—prostate cancer	5.04e-06	0.000362	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KDR—prostate cancer	4.98e-06	0.000358	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ESR1—prostate cancer	4.96e-06	0.000357	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ESR1—prostate cancer	4.85e-06	0.000349	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—BAD—prostate cancer	4.84e-06	0.000348	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—BAD—prostate cancer	4.74e-06	0.000341	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—APC—prostate cancer	4.69e-06	0.000337	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	4.69e-06	0.000337	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EGF—prostate cancer	4.63e-06	0.000334	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IRS1—prostate cancer	4.63e-06	0.000334	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	4.59e-06	0.00033	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—APC—prostate cancer	4.59e-06	0.00033	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IRS1—prostate cancer	4.53e-06	0.000326	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EGF—prostate cancer	4.53e-06	0.000326	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	4.5e-06	0.000324	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—INS—prostate cancer	4.44e-06	0.000319	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	4.4e-06	0.000317	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	4.35e-06	0.000313	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—INS—prostate cancer	4.34e-06	0.000312	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IGF1—prostate cancer	4.29e-06	0.000309	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	4.27e-06	0.000307	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	4.25e-06	0.000306	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IGF1—prostate cancer	4.2e-06	0.000302	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	4.18e-06	0.000301	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	4.15e-06	0.000299	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	4.12e-06	0.000297	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	4.08e-06	0.000294	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	4.08e-06	0.000293	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	4.06e-06	0.000292	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	4.04e-06	0.00029	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	4.03e-06	0.00029	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	3.99e-06	0.000287	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	3.99e-06	0.000287	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	3.95e-06	0.000284	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—FGF2—prostate cancer	3.95e-06	0.000284	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—NOS3—prostate cancer	3.89e-06	0.00028	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—FGF2—prostate cancer	3.86e-06	0.000278	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—NOS3—prostate cancer	3.81e-06	0.000274	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—JAK2—prostate cancer	3.78e-06	0.000272	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	3.71e-06	0.000267	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—JAK2—prostate cancer	3.7e-06	0.000266	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MDM2—prostate cancer	3.69e-06	0.000266	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	3.64e-06	0.000262	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	3.63e-06	0.000261	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MDM2—prostate cancer	3.61e-06	0.00026	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	3.59e-06	0.000259	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	3.56e-06	0.000256	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	3.51e-06	0.000253	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	3.45e-06	0.000248	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	3.38e-06	0.000243	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	3.37e-06	0.000243	CbGpPWpGaD
Pirbuterol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	3.34e-06	0.00024	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CASP3—prostate cancer	3.3e-06	0.000238	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL2—prostate cancer	3.3e-06	0.000237	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	3.3e-06	0.000237	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—IL6—prostate cancer	3.28e-06	0.000236	CbGpPWpGaD
Pirbuterol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	3.26e-06	0.000235	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CASP3—prostate cancer	3.23e-06	0.000233	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL2—prostate cancer	3.23e-06	0.000232	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CCND1—prostate cancer	3.22e-06	0.000232	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—IL6—prostate cancer	3.21e-06	0.000231	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	3.19e-06	0.000229	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CCND1—prostate cancer	3.15e-06	0.000226	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MMP9—prostate cancer	3.12e-06	0.000225	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	3.12e-06	0.000224	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	3.11e-06	0.000224	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PTEN—prostate cancer	3.1e-06	0.000223	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MMP9—prostate cancer	3.05e-06	0.00022	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	3.04e-06	0.000219	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PTEN—prostate cancer	3.04e-06	0.000219	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	3.03e-06	0.000218	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	2.96e-06	0.000213	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EP300—prostate cancer	2.96e-06	0.000213	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EP300—prostate cancer	2.9e-06	0.000208	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—SRC—prostate cancer	2.88e-06	0.000207	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—SRC—prostate cancer	2.82e-06	0.000203	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	2.8e-06	0.000202	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—STAT3—prostate cancer	2.78e-06	0.0002	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	2.74e-06	0.000197	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—STAT3—prostate cancer	2.72e-06	0.000195	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—MYC—prostate cancer	2.58e-06	0.000186	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	2.57e-06	0.000185	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—MYC—prostate cancer	2.52e-06	0.000182	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—EGFR—prostate cancer	2.52e-06	0.000182	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	2.52e-06	0.000181	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—EGFR—prostate cancer	2.47e-06	0.000178	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—KRAS—prostate cancer	2.38e-06	0.000172	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—KRAS—prostate cancer	2.33e-06	0.000168	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	2.19e-06	0.000158	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	2.14e-06	0.000154	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—TP53—prostate cancer	2.12e-06	0.000153	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—TP53—prostate cancer	2.07e-06	0.000149	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—IL6—prostate cancer	1.94e-06	0.00014	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—IL6—prostate cancer	1.9e-06	0.000137	CbGpPWpGaD
Pirbuterol—ADRB1—Signaling Pathways—AKT1—prostate cancer	1.79e-06	0.000129	CbGpPWpGaD
Pirbuterol—ADRB2—Signaling Pathways—AKT1—prostate cancer	1.75e-06	0.000126	CbGpPWpGaD
